Anal cytological abnormalities and human papilloma virus in kidney transplant recipients

Background: Transplant recipients have significantly elevated risk of anal cancer, compared to the general population. We sought to determine the presence of high risk human papilloma virus (hrHPV) and anal cytological abnormalities in kidney transplant recipients, and assess the feasibility of an a...

Full description

Bibliographic Details
Main Authors: Richard Hillman, Julian Langton-Lockton, Brenda Rosales, Jennifer Roberts, Alyssa Cornall, Andrew Grulich, Angela Webster
Format: Article
Language:English
Published: Elsevier 2018-06-01
Series:Papillomavirus Research
Online Access:http://www.sciencedirect.com/science/article/pii/S2405852118300612
id doaj-9f4e55b54ffa4c4c88c196a836d3b228
record_format Article
spelling doaj-9f4e55b54ffa4c4c88c196a836d3b2282020-11-25T01:03:45ZengElsevierPapillomavirus Research2405-85212018-06-015S6Anal cytological abnormalities and human papilloma virus in kidney transplant recipientsRichard Hillman0Julian Langton-Lockton1Brenda Rosales2Jennifer Roberts3Alyssa Cornall4Andrew Grulich5Angela Webster6Dysplasia and Anal Cancer Services, St Vincent's Hospital, Sydney, NSW, AustraliaLevel 1, 270 Roma Street, Biala Community Health Centre, Brisbane 4000, Qld, AustraliaSydney School of Public Health, University of Sydney, Sydney, AustraliaDouglas Hanly Moir Pathology, Sydney, AustraliaMolecular Microbiology, Murdoch Children's Research Institute, Melbourne, AustraliaThe Kirby Institute, Sydney, AustraliaSydney School of Public Health, University of Sydney, Sydney, Australia; Renal Medicine and Transplantation, Westmead Hospital, Sydney, AustraliaBackground: Transplant recipients have significantly elevated risk of anal cancer, compared to the general population. We sought to determine the presence of high risk human papilloma virus (hrHPV) and anal cytological abnormalities in kidney transplant recipients, and assess the feasibility of an anal cancer screening intervention. Methods: Kidney transplant recipients, over 18 years old, attending a Transplant Clinic, had anal swab specimens collected. These were then eluted into liquid-based cytology collection vials for cytological examination and HPV genotyping by Linear Array. Results: Of 102 participants approached, 73 (72%) consented to join the study and completed testing. The mean age was 47 (range 20–76 years). 64 (88%) had technically satisfactory cellularity. Of these, 8 (12.5%) were abnormal; 6 (9.4%) LSIL; 2 (3.1%) HSIL and 56 negative. 70 (96%) specimens were assessable for genotyping and 15 (21%) had HPV detected. 63 had both HPV and cytology assessable. Of the 15 with HPV, 4 (27%) had abnormal cytology, compared to 4 (7%) of 48 with no HPV. However, there was no evidence of an association between any HPV detection (low or high risk) and abnormal anal cytology (OR 2.75, 95% CI 0.82–11.84); p=0.12). Both participants with cytological HSIL had histological HSIL on HRA, both with multiple hrHPV. Conclusions: Transplant recipients were generally willing to consent to the study procedures, including anal swabbing. The prevalence of abnormal cytology was 12.5% and high risk HPV genotypes 12.3%. Anal swabbing was able to identify individuals at increased risk of anal cancer for future close monitoring.http://www.sciencedirect.com/science/article/pii/S2405852118300612
collection DOAJ
language English
format Article
sources DOAJ
author Richard Hillman
Julian Langton-Lockton
Brenda Rosales
Jennifer Roberts
Alyssa Cornall
Andrew Grulich
Angela Webster
spellingShingle Richard Hillman
Julian Langton-Lockton
Brenda Rosales
Jennifer Roberts
Alyssa Cornall
Andrew Grulich
Angela Webster
Anal cytological abnormalities and human papilloma virus in kidney transplant recipients
Papillomavirus Research
author_facet Richard Hillman
Julian Langton-Lockton
Brenda Rosales
Jennifer Roberts
Alyssa Cornall
Andrew Grulich
Angela Webster
author_sort Richard Hillman
title Anal cytological abnormalities and human papilloma virus in kidney transplant recipients
title_short Anal cytological abnormalities and human papilloma virus in kidney transplant recipients
title_full Anal cytological abnormalities and human papilloma virus in kidney transplant recipients
title_fullStr Anal cytological abnormalities and human papilloma virus in kidney transplant recipients
title_full_unstemmed Anal cytological abnormalities and human papilloma virus in kidney transplant recipients
title_sort anal cytological abnormalities and human papilloma virus in kidney transplant recipients
publisher Elsevier
series Papillomavirus Research
issn 2405-8521
publishDate 2018-06-01
description Background: Transplant recipients have significantly elevated risk of anal cancer, compared to the general population. We sought to determine the presence of high risk human papilloma virus (hrHPV) and anal cytological abnormalities in kidney transplant recipients, and assess the feasibility of an anal cancer screening intervention. Methods: Kidney transplant recipients, over 18 years old, attending a Transplant Clinic, had anal swab specimens collected. These were then eluted into liquid-based cytology collection vials for cytological examination and HPV genotyping by Linear Array. Results: Of 102 participants approached, 73 (72%) consented to join the study and completed testing. The mean age was 47 (range 20–76 years). 64 (88%) had technically satisfactory cellularity. Of these, 8 (12.5%) were abnormal; 6 (9.4%) LSIL; 2 (3.1%) HSIL and 56 negative. 70 (96%) specimens were assessable for genotyping and 15 (21%) had HPV detected. 63 had both HPV and cytology assessable. Of the 15 with HPV, 4 (27%) had abnormal cytology, compared to 4 (7%) of 48 with no HPV. However, there was no evidence of an association between any HPV detection (low or high risk) and abnormal anal cytology (OR 2.75, 95% CI 0.82–11.84); p=0.12). Both participants with cytological HSIL had histological HSIL on HRA, both with multiple hrHPV. Conclusions: Transplant recipients were generally willing to consent to the study procedures, including anal swabbing. The prevalence of abnormal cytology was 12.5% and high risk HPV genotypes 12.3%. Anal swabbing was able to identify individuals at increased risk of anal cancer for future close monitoring.
url http://www.sciencedirect.com/science/article/pii/S2405852118300612
work_keys_str_mv AT richardhillman analcytologicalabnormalitiesandhumanpapillomavirusinkidneytransplantrecipients
AT julianlangtonlockton analcytologicalabnormalitiesandhumanpapillomavirusinkidneytransplantrecipients
AT brendarosales analcytologicalabnormalitiesandhumanpapillomavirusinkidneytransplantrecipients
AT jenniferroberts analcytologicalabnormalitiesandhumanpapillomavirusinkidneytransplantrecipients
AT alyssacornall analcytologicalabnormalitiesandhumanpapillomavirusinkidneytransplantrecipients
AT andrewgrulich analcytologicalabnormalitiesandhumanpapillomavirusinkidneytransplantrecipients
AT angelawebster analcytologicalabnormalitiesandhumanpapillomavirusinkidneytransplantrecipients
_version_ 1725199658621337600